Leonard S. Schleifer, Chief Executive Officer & President, 10% Owner at REGENERON PHARMACEUTICALS INC (REGN), sold 150,000 shares at $23.00 ($3.4M) on 2006-11-07, disclosed to the SEC on 2006-11-08.
Scheduled sale ($3.4M) by Chief Executive Officer & President, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.25 | 5,301 | $118K | 3.5% |
| 2 | $22.25 | 11,685 | $260K | 7.7% |
| 3 | $22.25 | 31,493 | $701K | 20.7% |
| 4 | $22.25 | 47,535 | $1.1M | 31.2% |
| 5 | $23.00 | 781 | $18K | 0.5% |
| 6 | $23.01 | 700 |
| $16K |
| 0.5% |
| 7 | $23.02 | 7 | $161 | 0.0% |
| 8 | $23.03 | 300 | $7K | 0.2% |
| 9 | $23.04 | 100 | $2K | 0.1% |
| 10 | $23.06 | 400 | $9K | 0.3% |
| 11 | $23.08 | 99 | $2K | 0.1% |
| 12 | $23.10 | 8,600 | $199K | 5.9% |
| 13 | $23.11 | 16,400 | $379K | 11.2% |
| 14 | $23.15 | 23,600 | $546K | 16.1% |
| 15 | $23.15 | 1,799 | $42K | 1.2% |
| 16 | $23.20 | 700 | $16K | 0.5% |
| 17 | $23.21 | 100 | $2K | 0.1% |
| 18 | $23.22 | 200 | $5K | 0.1% |
| 19 | $23.23 | 100 | $2K | 0.1% |
| 20 | $23.25 | 100 | $2K | 0.1% |
| Total | $22.57 avg | 150,000 | $3.4M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |